Informazione tecnica HSE / 25 ° anno
/ Documenti disponibili:
43.922
/ Documenti scaricati: 31.178.759
/ Documenti scaricati: 31.178.759
Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
ID 22426 | 13.08.2024
Rettifica del regolamento (UE) 2024/1328 della Commissione, del 16 maggio 2024, che modifica l’allegato XVII del regolamento (CE) ...
EIGA Doc. 06/19
A liquid hydrogen storage installation on a user's premises is defined for the purpose of this publication as the installe...
UNECE convention on the transboundary effects of industrial accidents & the EU Directive 96/82/EC (SEVESO ll) by a consistent Chec...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024